Health Affairs April 29, 2024
Vikhyat S. Bebarta, Robert L. Mabry, Arthur L. Kellermann

Repurposing a Food and Drug Administration (FDA)-approved drug for a new use has been informally practiced for years. In fact, “off-label” medication administration is so common that the Congressional Research Service estimates that nearly 40 percent of prescriptions in the US are written for this purpose. A prime example is using ketamine to treat acute pain in emergency care settings. In this commentary, we explain how this practice came about, the advantages of using ketamine to treat acute pain, and the benefits that could be derived if the FDA approved this indication.

Background

Morphine has been the mainstay of treating pain since the Civil War. Early on, physicians recognized that morphine could cause serious adverse effects, including addiction if administered...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices
Will Trump's healthcare appointments bring 'radical changes'?

Share This Article